1.7 ML denosumab-bnht 70 MG/ML Injection
- RxCUI
- 2717542
- RxNorm name
- 1.7 ML denosumab-bnht 70 MG/ML Injection
- Display name
- 1.7 ML denosumab-bnht 70 MG/ML Injection
- Full name
- 1.7 ML denosumab-bnht 70 MG/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761398 | Conexxence | denosumab-bnht | 351(k) Interchangeable | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BOMYNTRA | DENOSUMAB | Fresenius Kabi USA, LLC | 49d25732-e05d-47e4-98cb-67df04796d4b | 2025-03-31 | Warnings, Adverse reactions | 2717542 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 49d25732-e05d-47e4-98cb-67df04796d4b | denosumab-bnht 120 MG in 1.7 ML Injection [PSN] · 1.7 ML denosumab-bnht 70 MG/ML Injection [SCD] · denosumab-bnht 120 MG per 1.7 ML Injection [SY] · denosumab-bnht 70 MG/ML per 1.7 ML Injection [SY] | 4 | 3 | These highlights do not include all the information needed to use BOMYNTRA safely and effectively. See full prescribing information for BOMYNTRA. BOMYNTRA (denosumab-bnht) injection, for subcutaneous use Initial U.S. Approval: 2025 BOMYNTRA (denosumab-bnht) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betw | 20250331 |